Form 10-Q LA JOLLA PHARMACEUTICAL For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Form 10-Q LA JOLLA PHARMACEUTICAL For: Sep 30

La Jolla Pharmaceutical (LJPC) Misses Q3 EPS by 6c; Updates on GCS-100 Phase 2 in CKD

November 12, 2014 4:17 PM EST

La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31).

The company also announced that detailed results from its Phase 2 study of GCS-100 in chronic kidney disease (CKD) patients are being presented at a poster session (Glomerular and Tubulointerstitial Disease: Clinical Trials and Outcomes, November 13, 10:00 a.m. - 12:00 p.m. Eastern Standard Time,... More